MedTrace Logo

SALGOT; Stroke Arm Longitudinal Study at the University of GOThenburg

NCT01115348 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2017-02-02

No results posted yet for this study

Summary

Stroke is the most common cause for motor disability in the grown-up population in the Western world. In Sweden \> 80 % are above 65 years of age at onset (1).Areas in the brain, controlling the movement in the upper extremity (UE) are often damaged at a stroke, which leads to impaired function. This impairment of the UE often leads to limitations in activities of daily living and reductions in the level of social activities; therefore, interventions that will improve function are needed to reduce the consequences for the person living with stroke. The time course of recovery of the UE is not clear and therefore the optimal timing of the intervention for the person and its content (ways of intervention) uncertain.

The investigators have developed objective assessments of motor performance with new technology (kinematic analysis and virtual reality with haptics). Since having an impaired UE often results in reduced capacity in daily living and social activities, this might lead to decreased participation. To complement the traditional focus on body function, there is a need for assessments of the person's activity level and participation, as well as self-perceived function.

The results from this study will lay the ground for an intervention study focusing on improved function in the upper extremity.

Conditions

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Principal Investigators

  • Katharina Stibrant Sunnerhagen, MD, PhD · Göteborg University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-12-31
Completion
2017-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115348 on ClinicalTrials.gov